Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
Originally published as JHC exPRESS on December 12, 2005.
doi:10.1369/jhc.5A6755.2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.5A6755.2005v1
54/4/467    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Taniguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Taniguchi, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry
Volume 54 (4): 467-472, 2006
Copyright ©The Histochemical Society, Inc.

Expression of Tandem P Domain K+ Channel, TREK-1, in the Rat Carotid Body

Y. Yamamoto and K. Taniguchi

Laboratory of Veterinary Anatomy, Faculty of Agriculture, Iwate University, Morioka, Japan

Correspondence to: Y. Yamamoto, Laboratory of Veterinary Anatomy, Department of Veterinary Sciences, Faculty of Agriculture, Iwate University, Ueda 3-19-8, Morioka, Iwate 080-8550, Japan. E-mail: yyoshio{at}iwate-u.ac.jp


   Summary
Top
 Summary
Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 
TREK-1 is one of the important potassium channels for regulating membrane excitability. To examine the distribution of TREK-1 in the rat carotid body, we performed RT-PCR for mRNA expression and in situ hybridization and immunohistochemistry for tissue distribution of TREK-1. RT-PCR detected mRNA expression of TREK-1 in the carotid body. Furthermore, in situ hybridization revealed the localization of TREK-1 mRNA in the glomus cells. TREK-1 immunoreactivity was mainly distributed in the glomus cells and nerve fibers in the carotid body. TREK-1 may modulate potassium current of glomus cells and/or afferent nerve endings in the rat carotid body. (J Histochem Cytochem 54:467–472, 2006)

Key Words: 2P-domain potassium channel • carotid body • membrane potential • immunocytochemistry • rat


   Introduction
Top
 Summary
 Introduction
Materials and Methods
 Results
 Discussion
 Literature Cited
 
TANDEM P DOMAIN K+ (K2P) channels can be divided into several subfamilies (see review; Lesage 2003Go). The one of subfamily TREK (TWIK-related K+ channels) comprises three subunits: TREK-1, TREK-2, and TRAAK. These channels are regulated by polyunsaturated fatty acids, cellular volume, pH, and general anesthetics (see review; Kim 2003Go). Using reverse transcriptase–polymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemistry, it has been demonstrated that these channels are strongly expressed in the many organs including brain (Hervieu et al. 2001Go; Medhurst et al. 2001Go; Talley et al. 2001Go). Functionally, it is suggested that TREK-1 plays an important role in potent neuroprotection against ischemic injury (Lauritzen et al. 2000Go).

Several potassium channels show an oxygen-sensing property: TASK-1 in cerebellar granule neurons (Plant et al. 2002Go) and in glomus cells (Buckler et al. 2000Go); TASK1 and TASK-3 in H146 cells (Hartness et al. 2001Go); THIK-1 in glossopharyngeal neurons (Campanucci et al. 2003Go); Kv3.4 and Kv4.3 in rabbit glomus cells (Sanchez et al. 2002Go). However, TREK-1 sensitivity for oxygen is argued. Miller et al. (2003)Go reported that acute hypoxia occluded human TREK-1 expressed in the HEK293 cells under ischemic and/or acidotic conditions. Furthermore, it is reported that inhibited TREK-1 current by intracellular alkanization was further suppressed by hypoxia (Miller et al. 2004Go). On the contrary, other reports demonstrated that TREK-1 was not oxygen sensitive (Buckler and Honore 2005Go; Caley et al. 2005Go). Furthermore, it has been demonstrated that several oxygen-sensing potassium channels are present in the peripheral chemosensor, the carotid body. Voltage-gated potassium channels Kv3.4 and 4.3 were demonstrated in the rabbit glomus cells (Sanchez et al. 2002Go). TASK-1 and TASK-3 immunoreactivities were observed in the rat glomus cells (Yamamoto et al. 2002Go).

To examine the distribution of TREK-1 in the rat carotid body, we performed RT-PCR for mRNA expression and in situ hybridization and immunohistochemistry for tissue distribution of TREK-1. Furthermore, double immunofluorescence by use of several cell markers was performed to identify cellular distribution of TREK-1.


   Materials and Methods
Top
 Summary
 Introduction
 Materials and Methods
Results
 Discussion
 Literature Cited
 
Animals
Wistar rats of both sexes (n=10) were used in our studies, which were approved by the local Ethics Committee. For RT-PCR analysis, four rats were sacrificed in the chamber filled with diethyl ether gas, and the bifurcations of carotid arteries were corrected. Whole carotid body was further dissected out with dissecting microscope and moved into RNA stabilization reagent (RNAlater; Qiagen, Tokyo, Japan). For immunohistochemistry and in situ hybridization, six rats were anesthetized intraperitoneally with pentobarbital (15 mg/kg) and transcardially perfused with Ringer's solution (500 ml) followed by Zamboni's fixative (4% paraformaldehyde, 0.5% picric acid in 0.1 M phosphate buffer; pH 7.4, 500 ml). The bifurcations of carotid arteries were dissected out and further fixed in the same fixative for 5 hr. The tissues were then soaked in 30% sucrose in phosphate-buffered saline (PBS; pH 7.4) and frozen. They were serially sectioned at 8 µm and mounted on glass slides coated with chrome alum–gelatin.

RT-PCR Amplification
Two carotid bodies were mechanically homogenized for 5 min, and RNA was then extracted by commercial kit (RNeasy Fibrous tissue kit; Qiagen). mRNA templates were incubated with DNAase I (Takara; Tokyo, Japan) for 30 min at 37C before use. RT-PCR was performed by use of Qiagen OneStep RT-PCR kit with specific primers for TREK-1. For positive control, primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were also used to detect mRNA expression of housekeeping gene. Primers for TREK-1 and GAPDH are shown in Table 1 . Reverse transcription was done for 30 min at 50C, and initial PCR activation was then performed for 15 min at 95C. PCR amplification was performed for 40 times as follows: 30 sec at 94C for denaturation, 30 sec at 55C for annealing, 1 min at 72C for extension. After PCR amplification, samples were applied for 10 min at 72C for final extension. PCR end products were visualized on 2% agarose gels with ethidium bromide. For negative control experiment, mRNA template was omitted.


View this table:
[in this window]
[in a new window]
  		Table 1

Primers for RT-PCR

 
In Situ Hybridization
For in situ hybridization, sections were washed with PBS and then rinsed with 5x SSC. The sections were incubated with 50% formamide in 5x SSC including 1 µg/ml digoxygenin-labeled oligonucleotide probe for TREK-1 (accession number AF385402; position 1264–1308; 5'-CACCGACAGGGTCCTCCTACATGGAGTCAGTTCCTGGTTATGGTT-3') with 40 µg/ml fragmented salmon sperm DNA for 15 hr at 50C. Sections were then washed in 5x SSC, 2x SSC, 0.1x SSC, and buffer 1 (constitute; 100 mM Tris, 150 mM NaCl, pH 7.5) and incubated with 1% normal goat serum in buffer 1 for 1 hr at room temperature. Sections were then washed with buffer 1 and reacted with alkaline phosphatase-labeled sheep anti-digoxygenin antibody Fab fragment (1:2000; Roche Diagnostics, Mannheim, Germany) for 2 hr at 40C. Sections were washed with buffer 1 and buffer 3 (100 mM Tris, 150 mM NaCl, 50 mM MgCl2, pH 9.5) and incubated with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium solution for visualization of reacted sites. For positive control, antisense dioxygenin-labeled oligonucleotide probe for poly-A was used. For negative control, randomized digoxygenin-labeled oligonucleotide probes were used.

Immunohistochemistry
Sections were incubated for 60 min with non-immune donkey serum (1:50) and rinsed with phosphate-buffered saline (PBS; pH 7.4). Sections were then incubated overnight at 4C with goat polyclonal antisera against TREK-1. After incubation, sections were washed again with PBS and treated with TRITC-labeled donkey antibody against goat IgG for 2 hr at room temperature. After washing with PBS, sections were mounted in glycerol-PBS and examined with an epifluorescence microscope (E-600; Nikon, Tokyo, Japan). Negative controls were incubated with preabsorbed antibody using blocking peptide (SC-11556P; Santa Cruz Biotechnology, Santa Cruz, CA), 1 µg antigen/1 µg antibody, or PBS. Details of antibodies are shown in Table 2 .


View this table:
[in this window]
[in a new window]
  		Table 2

Antibodies used in the present study

 
Double Immunofluorescence
Cryostat sections were also used for double immunofluorescence for TREK-1 with synaptophysin, glial fibrillary acidic protein (GFAP), vimentin, or {alpha}-smooth muscle actin (ASMA). After incubation with normal donkey serum, sections were incubated with goat polyclonal TREK-1 together with antibody against mouse monoclonal antibody against synaptophysin, rabbit polyclonal antibody against GFAP, mouse monoclonal antibody against vimentin, or mouse monoclonal antibody against ASMA for 12 hr at 4C. Sections were then incubated with a mixture of TRITC-labeled donkey anti-goat IgG with FITC-labeled donkey anti-mouse IgG or with FITC-labeled donkey anti-rabbit IgG for 2 hr at 25C. Sections were coverslipped with glycerol-PBS and examined under an epifluorescence microscope. Details of antibodies are shown in Table 2.


   Results
Top
 Summary
 Introduction
 Materials and Methods
 Results
Discussion
 Literature Cited
 
RT-PCR
Using RT-PCR, mRNA expressions of TREK-1 and GAPDH were detected at 125 and 401 bp, respectively (Figure 1 , Lanes 2 and 3). In the negative control experiment, no product was found (Figure 1, Lane 4).


Figure 1
View larger version (40K):
[in this window]
[in a new window]
  		Figure 1

RT-PCR for TREK-1 mRNA in the rat carotid body. The appropriate-sized PCR product is visualized. 1, 100-bp molecular weight marker; 2, carotid body; 3, glyceraldehyde-3-phosphate dehydrogenase (GAPDH); 4, negative control for TREK-1.

 
In Situ Hybridization
Intense signals for TREK-1 mRNA were observed in the cytoplasm of the glomus cells by in situ hybridization (Figures 2A and 2B). Ubiquitous distribution of mRNA signals was observed in positive control section that stained with probe for poly-A sequence (Figure 2C). No signal was observed in the negative control (Figure 2D).


Figure 2
View larger version (32K):
[in this window]
[in a new window]
  		Figure 2

In situ hybridization for TREK-1 mRNA in the carotid body. Positive signals for TREK-1 are present in the glomus cells (GC). Rectangle in (A) is enlarged in (B). Positive and negative controls for poly-A (C) and randomized sequences (D).

 
Immunohistochemistry
Immunoreactivity for TREK-1 was observed in the rat carotid body (Figures 3A and 3B). Sections incubated with either PBS or preabsorbed antibody instead of primary antibody showed no immunoreactivity (Figure 3C). Glomus cells and nerve fibers with various thicknesses were strongly immunoreactive for TREK-1. Furthermore, dot-like structures with immunoreactivity for TREK-1 were observed around the clusters of glomus cells. Vascular endothelial cells were also immunoreactive, but fibroblasts were not immunoreactive for TREK-1.


Figure 3
View larger version (73K):
[in this window]
[in a new window]
  		Figure 3

Immunolocalization of TREK-1 in the rat carotid body. Rectangle in (A) is enlarged in (B). Glomus cells (GC), several nerve fibers (NF), and vascular endothelial cells in the blood vessels (EC) are immunoreactive for TREK-1. Many dot-like structures with immunoreactivity for TREK-1 are shown around the clusters of glomus cells. No positive reaction is shown in the section stained with preabsorbed antibody (C).

 
Double Immunofluorescence
Immunoreactive sites for synaptophysin, the general marker for glomus cells, were also immunoreactive for TREK-1 (Figures 4A –4C). Immunoreactive sites for GFAP, marker for sustentacular cells, and for vimentin, marker for sustentacular cells and fibroblasts, did not show TREK-1 immunoreactivity (Figures 4D–4I). GFAP-immunoreactive Schwann cells were observed in the nerve bundles in the carotid body but were not immunoreactive for TREK-1. Vascular smooth muscle cells immunoreacted for ASMA were not immunoreactive for TREK-1 (Figures 4J–4L).


Figure 4
View larger version (139K):
[in this window]
[in a new window]
  		Figure 4

Double immunofluorescence for TREK-1 combined with synaptophysin (A–C), glial fibrillary acidic protein (GFAP) (D–F), vimentin (G–I), and {alpha}-smooth muscle actin (ASMA) (J–L). (C,F,I,L) Merged image of (A,B), (D,E), (G,H), and (J,K), respectively. Glomus cells that are immunoreactive for TREK-1 GC in (A,D,G,J) are also immunoreactive for synaptophysin (GC) but not immunoreactive for GFAP (E), vimentin (H), and ASMA (K). TREK-1-immunoreactive nerve fibers (NF in D) and endothelial cells (EC in J) are not immunoreactive for GFAP (E) and for ASMA (K), respectively. GFAP-immunoreactive sustentacular cells (SC in E) and Schwann cells (Sch in E), vimentin-immunoreactive sustentacular cells (SC in H) and fibroblasts (Fb in H), and ASMA-immunoreactive vascular smooth muscle cells (SMC in K) are not immunoreactive for TREK-1.

 

   Discussion
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
Literature Cited
 
It has been reported that TREK-1 is mainly expressed in the central nervous system at mRNA level (Medhurst et al. 2001Go; Talley et al. 2001Go) and protein level (Hervieu et al. 2001Go). Furthermore, expression of TREK-1 is also reported in other excitatory cells such as trigeminal and petrosal ganglion cells (Matsumoto et al. 2001Go), smooth muscle cells (Koh et al. 2001Go), and cardiomyocyte (Tan et al. 2004Go). TREK-1 in the glomus cells and possibly afferent nerve fibers in the carotid body, which was revealed in the present study, may indicate TREK-1 would be expressed in the peripheral chemosensory cells. The dot-like structures around the glomus cells may be the TREK-1 channels bound to excitable membrane of nerve fibers and nerve endings. Our previous study demonstrated that immunoreactivities for other K2P channels, TASK-1, TASK-2, TASK-3, and TRAAK, were found in the glomus cells and/or nerve fibers in the carotid body (Yamamoto et al. 2002Go). Thus, the glomus cell and nerve fibers in the rat carotid body expressed a wide variety of K2P channels to modulate K+ current of resting membrane and/or depolarizing membrane potential.

It has been reported that acute hypoxia occluded human TREK-1 expressed in the HEK293 cells under ischemic and/or acidotic conditions (Miller et al. 2003Go) and that inhibited TREK-1 current by intracellular alkalization was further suppressed by hypoxia (Miller et al. 2004Go). If TREK-1 were an oxygen-sensitive channel, it would be closed by hypoxic stimulation to modulate the cellular membrane of glomus cells in cooperation with other oxygen-sensing potassium channels, e.g., TASK-1, TASK-3, Kv3.4, and Kv4.3. Furthermore, it has been reported that TREK-1 is inhibited by glutamate via group 1 metabotropic glutamate receptors (Chemin et al. 2003Go). During hypoxia, glutamate is released in the nucleus tractus solitarii that is the central terminal part of the carotid sinus nerve (Mizusawa et al. 1994Go). Torrealba et al. (1996)Go reported that glutamate is not released from the cat carotid body even in the high concentration of potassium. However, glutamate is still a candidate of excitatory transmitter between the glomus cells and afferent nerve endings, because glutamate-immunoreactive glomus cells and nerve fibers were observed in the carotid body of cat (Torrealba et al. 1996Go) and guinea pig (Kummer 1997Go). Thus, TREK-1 may enhance membrane excitation of the glomus cells via involvement of glutamatergic neurotransmission in addition to direct occlusion during hypoxia.

On the contrary, other reports demonstrated that TREK-1 was not oxygen sensitive (Buckler and Honore 2005Go; Caley et al. 2005Go). If TREK-1 is not an oxygen-sensitive molecule, another hypothesis for TREK-1 function is raised. Generally, it is suggested that TREK-1 acts as a potent neuroprotector (Duprat et al. 2000Go; Lauritzen et al. 2000Go). It opens with arachidonic acid and certain phospholipids such as phosphatidylinositol 4-monophosphate and phosphatidylinositol 4,5-bisphosphate (Maingret et al. 2000Go). In the carotid body, hypoxia increased the activity of phospholipase C, one of the important enzymes for generation of phospholipids (Pokorski and Strosznajder 1993Go). Furthermore, Ca2+ enhanced the production of arachidonic acid in homogenized samples of the carotid body (Strosznajder 1996Go). According to these reports, TREK-1 may act for cellular protection. A second hypothesis is that TREK-1 in the glomus cells may close with arachidonic acid generated under hypoxia to protect membrane excitation.

In conclusion, TREK-1 would be important for K+ current modulation of the glomus cells and/or afferent nerve endings in the rat carotid body. However, two contradictory hypotheses on TREK-1 function are proposed at present. One hypothesis is that TREK-1 enhances membrane depolarization of glomus cells by hypoxic stimulation. A second hypothesis is that it is protected via phospholipids and/or arachidonic acid. To clarify the exact function of TREK-1 in the carotid body, further studies are needed.


   Acknowledgments
 
This study was supported in part by the Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS), Japan (15780185).


   Footnotes
 
Received for publication June 13, 2005; accepted November 22, 2005


   Literature Cited
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 

Buckler KJ, Honore E (2005) The lipid-activated two-pore domain K+ channel TREK-1 is resistant to hypoxia: implication for ischaemic neuroprotection. J Physiol 562:213–222[Abstract/Free Full Text]

Buckler KJ, Williams BA, Honore E (2000) An oxygen-, acid-, and anesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol 525:135–142[Abstract/Free Full Text]

Caley AJ, Gruss M, Franks NP (2005) The effects of hypoxia on the modulation of human TREK-1 potassium channels. J Physiol 562:205–212[Abstract/Free Full Text]

Campanucci VA, Fearon IM, Nurse CA (2003) A novel O2-sensing mechanism in rat glossopharyngeal neurons mediated by a halothane-inhibitable background K+ conductance. J Physiol 548:731–743[Abstract/Free Full Text]

Chemin J, Girard C, Duprat F, Lesage F, Romey G, Lazdunski M (2003) Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels. EMBO J 20:5403–5411[CrossRef]

Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M (2000) The neuroprotective agent riluzole activates the two P domain K+ channels TREK-1 and TRAAK. Mol Pharmacol 57:906–912[Abstract/Free Full Text]

Hartness ME, Lewis A, Searle GJ, O'Kelly I, Peers C, Kemp PJ (2001) Combined antisense and pharmacological approaches implicate hTASK as an airway O2 sensing K+ channel. J Biol Chem 276:26499–26508[Abstract/Free Full Text]

Hervieu GJ, Cluderay JE, Gray CW, Green PJ, Ranson JL, Randall AD, Meadows HJ (2001) Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103:899–919[CrossRef][Medline]

Kim D (2003) Fatty acid-sensitive two-pore domain K+ channels. Trends Pharmacol Sci 24:648–654[CrossRef][Medline]

Koh SD, Monagham K, Sergeant GP, Ro S, Walker RL, Sanders KM, Horowitz B (2001) TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase: an essential role in smooth muscle inhibitory neurotransmission. J Biol Chem 47:44338–44346

Kummer W (1997) Innervation of paraganglia. In Unsicker K, ed. Anatomic–Endocrine Interactions. London, Taylor & Francis, 315–356

Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M (2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19:1784–1793[CrossRef][Medline]

Lesage F (2003) Pharmacology of neuronal background potassium channels. Neuropharmacology 44:1–7[CrossRef][Medline]

Maingret F, Patel AJ, Lesage F, Lazdunski M, Honoré E (2000) Lysophospholipids open the two-pore domain mechano-gated K+ channels TREK-1 and TRAAK. J Biol Chem 275:10128–10133[Abstract/Free Full Text]

Matsumoto I, Emori Y, Ninomiya Y, Abe K (2001) A comparative study of three cranial sensory ganglia projecting into the oral cavity: in situ hybridization analyses of neurotrophin receptors and thermosensitive cation channels. Brain Res Mol Brain Res 93:105–112[Medline]

Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD,Kelsell RE, Gloger II, et al. (2001) Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 86:101–114[Medline]

Miller P, Kemp PJ, Lewis A, Chapman CG, Meadows HJ, Peers C (2003) Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection. J Physiol 548:31–37[Abstract/Free Full Text]

Miller P, Peers C, Kemp PJ (2004) Polymodal regulation of hTREK1 by pH, arachidonic acid, and hypoxia: physiological impact in acidosis and alkalosis. Am J Physiol Cell Physiol 286:C272–282[Abstract/Free Full Text]

Mizusawa A, Ogawa H, Kikuchi Y, Hida W, Kurosawa H, Okabe S, Takishima T, et al. (1994) In vivo release of glutamate in nucleus tractus solitarii of the rat during hypoxia. J Physiol 478:55–66[Abstract/Free Full Text]

Plant LD, Kemp PJ, Peers C, Henderson Z, Pearson HA (2002) Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke 33:2324–2328[Abstract/Free Full Text]

Pokorski M, Strosznajder R (1993) pO2-dependence of phospholipase C in the cat carotid body. Adv Exp Med Biol 337:191–195[Medline]

Sanchez D, Lopez-Lopez JR, Perez-Garcia MT, Sanz-Alfayate G, Obeso A, Ganfornina MD, Gonzalez C (2002) Molecular identification of KV{alpha} subunits that contribute to the oxygen sensitive K+ current of chemoreceptor cells of the rabbit carotid body. J Physiol 542:369–382[Abstract/Free Full Text]

Strosznajder RP (1996) Acute hypoxia modulates arachidonic acid metabolism in cat carotid bodies. Role of dopamine. Acta Neurobiol Exp (Wars) 56:535–543[Medline]

Talley EM, Solórzano G, Lei Q, Kim D, Bayliss DA (2001) CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 21:7491–7505[Abstract/Free Full Text]

Tan JH, Liu W, Saint DA (2004) Differential expression of the mechanosensitive potassium channel TREK-1 in epicardial and endocardial myocytes in rat ventricle. Exp Physiol 89:237–242[Abstract/Free Full Text]

Torrealba F, Bustos G, Montero VM (1996) Glutamate in the glomus cells of the cat carotid body: immunocytochemistry and in vitro release. Neurochem Int 28:625–631[CrossRef][Medline]

Yamamoto Y, Kummer W, Atoji Y, Suzuki Y (2002) TASK-1, TASK-2, TASK-3 and TRAAK immunoreactivities in the rat carotid body. Brain Res 950:304–307[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Physiol.Home page
R. Varas, C. N. Wyatt, and K. J. Buckler
Modulation of TASK-like background potassium channels in rat arterial chemoreceptor cells by intracellular ATP and other nucleotides
J. Physiol., September 1, 2007; 583(2): 521 - 536.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.5A6755.2005v1
54/4/467    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Taniguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Taniguchi, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact